SCHEMBL24907127

SCHEMBL24907127

NC(CO)C(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21401189 1.00
Hydrochloric Acid SCHEMBL20268360 0.97
Hydrochloric Acid SCHEMBL20268358 0.97
Hydrochloric Acid SCHEMBL25403230 0.97
SCHEMBL8886206 0.84
SCHEMBL2505750 0.84
Hydrochloric Acid SCHEMBL1478454 0.81 CYP2D6 (0.36)
SCHEMBL26670750 0.73
SCHEMBL20640563 0.73
SCHEMBL26670753 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166595-A1 PROCESS FOR THE PREPARATION OF BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS GENENTECH, INC. (US) 2024-05-23 US disclosed
EP-4347574-A1 PROCESS FOR THE PREPARATION OF BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS Genentech, Inc. (US) 2024-04-10 EP disclosed
CN-117377660-A Process for the preparation of benzoxazepine oxazolidinone compounds 基因泰克公司 2024-01-09 CN disclosed
EP-4165023-A1 INHIBITORS OF APOL1 AND USE OF THE SAME Vertex Pharmaceuticals Incorporated (US) 2023-04-19 EP disclosed
CN-115867532-A Inhibitors of APOL1 and uses thereof 弗特克斯药品有限公司 2023-03-28 CN disclosed
US-20230014907-A1 INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED 2023-01-19 US disclosed
WO-2022251567-A1 PROCESS FOR THE PREPARATION OF BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS GENENTECH, INC. (US) 2022-12-01 WO disclosed